Integrated therapeutic strategies for anaplastic thyroid carcinoma

Roberto Buzzoni; Laura Catena; Diego Cortinovis; Giuseppina Dognini; Emilio Bajetta

Integrated therapeutic strategies for anaplastic thyroid carcinoma

Roberto Buzzoni, Laura Catena, Diego Cortinovis, Giuseppina Dognini, Emilio Bajetta

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

Anaplastic thyroid carcinoma (ATC) is a very rare neoplasm with an aggressive course. The prognosis has not changed in the last decades and the median survival does not exceed six months. Only few patients with incidental limited ATC will be cured. Different therapeutic options have been explored but the results are disappointing. At present, new drugs and new timing for proper treatment are under investigation. In this short review we have summarized these recent developments.

Original language	English
Pages (from-to)	544-546
Number of pages	3
Journal	Tumori
Volume	89
Issue number	5
Publication status	Published - Sep 2003

Keywords

Anaplastic thyroid carcinoma
Chemotherapy
Integrated radiotherapeutic strategies

ASJC Scopus subject areas

Cancer Research

Access to Document

Fingerprint Dive into the research topics of 'Integrated therapeutic strategies for anaplastic thyroid carcinoma'. Together they form a unique fingerprint.

Cite this

@article{08f7e312087c4154aefc3b3bb44c8501,

title = "Integrated therapeutic strategies for anaplastic thyroid carcinoma",

abstract = "Anaplastic thyroid carcinoma (ATC) is a very rare neoplasm with an aggressive course. The prognosis has not changed in the last decades and the median survival does not exceed six months. Only few patients with incidental limited ATC will be cured. Different therapeutic options have been explored but the results are disappointing. At present, new drugs and new timing for proper treatment are under investigation. In this short review we have summarized these recent developments.",

keywords = "Anaplastic thyroid carcinoma, Chemotherapy, Integrated radiotherapeutic strategies",

author = "Roberto Buzzoni and Laura Catena and Diego Cortinovis and Giuseppina Dognini and Emilio Bajetta",

year = "2003",

month = sep,

language = "English",

volume = "89",

pages = "544--546",

journal = "Tumori",

issn = "0300-8916",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Integrated therapeutic strategies for anaplastic thyroid carcinoma

AU - Buzzoni, Roberto

AU - Catena, Laura

AU - Cortinovis, Diego

AU - Dognini, Giuseppina

AU - Bajetta, Emilio

PY - 2003/9

Y1 - 2003/9

N2 - Anaplastic thyroid carcinoma (ATC) is a very rare neoplasm with an aggressive course. The prognosis has not changed in the last decades and the median survival does not exceed six months. Only few patients with incidental limited ATC will be cured. Different therapeutic options have been explored but the results are disappointing. At present, new drugs and new timing for proper treatment are under investigation. In this short review we have summarized these recent developments.

AB - Anaplastic thyroid carcinoma (ATC) is a very rare neoplasm with an aggressive course. The prognosis has not changed in the last decades and the median survival does not exceed six months. Only few patients with incidental limited ATC will be cured. Different therapeutic options have been explored but the results are disappointing. At present, new drugs and new timing for proper treatment are under investigation. In this short review we have summarized these recent developments.

KW - Anaplastic thyroid carcinoma

KW - Chemotherapy

KW - Integrated radiotherapeutic strategies

UR - http://www.scopus.com/inward/record.url?scp=0347824358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347824358&partnerID=8YFLogxK

M3 - Article

C2 - 14870782

AN - SCOPUS:0347824358

VL - 89

SP - 544

EP - 546

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -